The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities. 

“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper, in a press release. 

Adding to the agency's concerns, the number of infections that were resistant to echinocandins, which is the antifungal medicine most commonly used to treat C. auris infections, tripled in 2021. 

The CDC classified C. auris as an "urgent antimicrobial resistance (AR) threat," meaning "it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates."

Between 2016, when C. auris was first reported, and 2021, there have been a total of 3,270 clinical cases reported and 7,413 screening cases. 

The agency said "poor general infection prevention and control (IPC) practices in healthcare facilities" are responsible for the spread. However, expanded efforts to detect cases is also responsible for the jump in reported cases.

Share:
More In Science
Overviewing California's Recent Oil Spill and What it's Doing to the Environment
The recent California oil spill has wreaked havoc on the shores of Huntington Beach as wildlife habitats and potentially some people have been exposed to the 140,000+ gallons of oil in the ocean. Cheddar News was joined by Dr. Deborah Bronsan, President of Deborah Bronson & Associates to learn more about the environmental dangers and how the area can recover from this tragedy.
Blue Bear Capital Raises $150 Million as It Helps Bolster Fight Against Climate Change
Blue Bear Capital, a venture and growth equity firm focusing on AI-powered solutions for the world’s energy, infrastructure, and climate challenges, recently announced it has raised $150 million dollars in new funding. Ernst Sack, Partner at Blue Bear Capital, joins Cheddar Climate the vision his company has when it comes to combating climate change.
Load More